Back to BANK OF MONTREAL /CAN/ BANK OF MONTREAL /CAN/

NGENNGEN
2 quarters

Position history for BANK OF MONTREAL /CAN/BANK OF MONTREAL /CAN/'s holdings in NERVGEN PHARMA CORP

BANK OF MONTREAL /CAN/ holds 78,394 shares of NGEN (NERVGEN PHARMA CORP), worth $284,382 as of 2026-Q2. The position was increased (+24.6% shares). NGEN represents 0.0% of BANK OF MONTREAL /CAN/'s portfolio.

Current Value

$284,382

Current Shares

78,394

Total Value Change

+$47,249

Total Shares Change

+15,494

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
78,394
+24.6%
$284,3820.0%$2.06
29
2026-Q1
New
62,900
-
$237,1330.0%$3.95
32

Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used